Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03638635 · ClinicalTrials.gov registry record · Phase 4
Standard Bupivacaine vs Liposomal Bupivacaine in Colorectal Patients
A Phase 4 study, sponsored by Inova Health Care Services.
- Terminated
- Registry status
- Phase 4
- Development phase
- 63
- Enrollment target
NCT03638635: Clinical Trial Phase 4 study, sponsored by Inova Health Care Services.
NCT03638635 is a Phase 4 study that was terminated before completion, run by Inova Health Care Services. The registered enrollment target is 63 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (88% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03638635, a Phase 4 study, was terminated before completion, sponsored by Inova Health Care Services.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 63 participants
- Enrollment target
Study Summary
The transversus abdominis plane (TAP) block can be used to reduce pain in patients who get abdominal surgery. TAP blocks are given with a local anesthetic. The purpose of this study is to compare pain medication usage after surgery between two different types of local anesthetic: liposomal bupivacaine and standard bupivacaine.
Primary Outcome
Daily overall opioid use recorded as morphine equivalents
Interventions
- DRUG Bupivacaine
- DRUG Bupivacaine liposome
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 63 participants |
| Start Date | 2018-05-14 |
| Est. Completion | 2019-01-16 |
| Phase | Phase 4 |
Why NCT03638635 stopped before completion
NCT03638635 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 63 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (88% lower).
The record links to 0 conditions, and to 2 interventions - of which Bupivacaine is the first listed.
NCT03638635 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03638635 about?
NCT03638635 is a clinical study titled "Standard Bupivacaine vs Liposomal Bupivacaine in Colorectal Patients". The transversus abdominis plane (TAP) block can be used to reduce pain in patients who get abdominal surgery. TAP blocks are given with a local anesthetic. The purpose of this study is to compare pain medication usage after surgery between two different types of local anesthetic: liposomal bupivacai...
What is the current status of trial NCT03638635?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 63 participants. The study started on 2018-05-14. Estimated completion is 2019-01-16.
What interventions are being tested in trial NCT03638635?
The interventions under investigation include: Bupivacaine (DRUG), Bupivacaine liposome (DRUG).
Who is sponsoring clinical trial NCT03638635?
This trial is sponsored by Inova Health Care Services, which has 75 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03638635's enrollment target sits among peer trials
63 1106th of 2000 higher than 891 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03383575 · 63 participants · Phase 2
Azacitidine and Enasidenib in Treating Patients With IDH2-Mutant Myelodysplastic Syndrome
- NCT04870944 · 63 participants · Phase 1
CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma
- NCT05031897 · 63 participants · Phase 2
Two Step Haplo With Radiation Conditioning
- NCT05312671 · 63 participants · Phase 2
Atezolizumab Plus Etoposide and Platinum in Small Cell Bladder Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI